• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 57 -6 (80) 2025 - Abdulloev M.Z. - PRACTICAL ANALYSIS OF THE EFFECTIVENESS OF ANTIVIRAL DRUGS IN THE TREATMENT OF HEPATITIS C

57 -6 (80) 2025 - Abdulloev M.Z. - PRACTICAL ANALYSIS OF THE EFFECTIVENESS OF ANTIVIRAL DRUGS IN THE TREATMENT OF HEPATITIS C

PRACTICAL ANALYSIS OF THE EFFECTIVENESS OF ANTIVIRAL DRUGS IN THE TREATMENT OF HEPATITIS C

Abdulloev M.Z. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Epidemiological features of patients with HCV infection who were under dispensary observation in polyclinics of the Bukhara region were studied, the number of patients was 125, of which 87 (69.6%) were women and 38 (30.4%) were men. Epidemiological diagnosis of HCV was performed by detecting the RNA and genotype of HCV virus infection in blood serum by polymerase chain reaction (PCR) in real time. The first genotype of the virus was detected in 87.2% (n=109) patients, 0.8% (n=1) the second, and 12% (n=15) the third. Complete elimination of viruses in 98.4% of cases was achieved using a combination of sofosbuvir and Daclatasvir, directly from antiviral drugs

Key words: HCV infection, PCR, sofosbuvir, daclatasvir

First page

289

Last page

292

For citation:Abdulloev M.Z. - PRACTICAL ANALYSIS OF THE EFFECTIVENESS OF ANTIVIRAL DRUGS IN THE TREATMENT OF HEPATITIS C//New Day in Medicine 6(80)2025 289-292 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Гепатит С. Информационные Бюллетени № 164 И № 204. Воз, 2013 [Gepatit С. Informatsionnyye Byulleteni № 164 I № 204. Voz, 2013 (In Russian).
  2. Нарзиев И.И., Облоқулов А.А., Фармонова М.А. И Др. Нсv Инфекция Давосида Антивирус Терапия Самара- Си// Новый День В Медицине.2019;1(25): 274-276.
  3. Сюткин В.Е. Новые Возможности Повышения Эффективности Противовирусной Терапии Больных Хрониче- Ским Гепатитом С / В.Е.Сюткин //Инфекционные Болезни – 2009; 2 : 55-58.
  4. Ющук Н. Д., Климова Е. А., Знойко О. О. И Др. ―Протокол Диагностики И Лечения Больных Вирусными Гепатитами В И С‖. Российский Журнал Гастроэнтерологии, Гепатологии, Колопроктологии. 2010; 6:4− 60. 5. Abdel-Moneim A, Ramadan S. Medication of Chronic Hepatitis C: A Review on Sofosbuvir As A New Antiviral Drug.
  5. Asrjets 2015; 13:1–23.
  6. Clinical Practice Guidelines: Easl Recommendations on Treatment of Hepatitis C. J Hepatol. 2015;63:199-236.
  7. Easl Recommendations on Treatment of Hepatitis C 2015. Journal of Hepatology. 2015; 63:199−236.
  8. Global Hepatitis Report, 2017: World Health Organization. URL: Http://Www.Who.Int/Hepatitis/Publications/Global- Hepatitis-Report2017/En.
  9. Ziyodulloyevich A. M. Цитомегаловирусная Инфекция //Ta'lim Innovatsiyasi Va Integratsiyasi. – 2025. – Т. 45. – №. 3. – С. 100-104.
  10. Nouh Ma, Ahmed Ali AA, El-Gazzarah Ar. Study the Efficacy of Sofosbuvir/Daclatasvir in Treatment of Hepatitis C Virus in Egypt. Menoufia Med J 2020;33:62-8.
  11. Облоқулов А., Абдуллоев М. Изучение Эффективности Противовирусных Препаратов Прямого Действия При Лечении Хронического Вирусного Гепатита С //Журнал Вестник Врача. – 2020. – Т. 1. – №. 3. – С. 70-73..

    file

    download